HB 1115 Summary: Prescription Drug Monitoring Program

• Prescribers are required to check the prescription drug monitoring program (PDMP) before prescribing the second fill of opioids or benzodiazepines; repeated failure to comply constitutes unprofessional conduct subject to discipline.

• Dentists, physicians, nurses, optometrists, podiatrists, pharmacists, and veterinarians must attest compliance with PDMP requirements during license renewal, with attestation requirements phased in starting July 1, 2024.

• Practitioners and pharmacists remain responsible for negligent breaches of confidentiality by their designees when accessing the program on their behalf.

• The state Division of Professions and Occupations is authorized to approve qualified integration organizations to help practitioners and pharmacists integrate PDMP access and data entry into their electronic medical records systems.

• The bill appropriates $2,016,475 from the prescription drug monitoring fund for the 2022-23 fiscal year, including $2 million for electronic medical records integration assistance, with remaining funds available through December 30, 2024.